JinXianDai Information Industry Co Ltd
SZSE:300830
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
J
|
JinXianDai Information Industry Co Ltd
SZSE:300830
|
CN |
|
Puma SE
XETRA:PUM
|
DE |
|
J
|
Jafron Biomedical Co Ltd
SZSE:300529
|
CN |
Income Statement
Earnings Waterfall
JinXianDai Information Industry Co Ltd
Income Statement
JinXianDai Information Industry Co Ltd
| Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
1
|
3
|
5
|
7
|
9
|
9
|
0
|
0
|
|
| Revenue |
170
N/A
|
251
+47%
|
494
+97%
|
506
+2%
|
509
+1%
|
523
+3%
|
599
+15%
|
598
0%
|
540
-10%
|
610
+13%
|
628
+3%
|
629
+0%
|
640
+2%
|
561
-12%
|
508
-9%
|
498
-2%
|
480
-4%
|
464
-3%
|
440
-5%
|
433
-1%
|
424
-2%
|
398
-6%
|
|
| Gross Profit | |||||||||||||||||||||||
| Cost of Revenue |
(96)
|
(140)
|
(275)
|
(284)
|
(286)
|
(299)
|
(345)
|
(353)
|
(322)
|
(359)
|
(369)
|
(377)
|
(383)
|
(337)
|
(277)
|
(275)
|
(267)
|
(263)
|
(248)
|
(244)
|
(238)
|
(223)
|
|
| Gross Profit |
74
N/A
|
110
+49%
|
219
+98%
|
222
+1%
|
223
+0%
|
225
+1%
|
254
+13%
|
245
-4%
|
218
-11%
|
250
+15%
|
259
+3%
|
252
-3%
|
257
+2%
|
224
-13%
|
231
+3%
|
223
-3%
|
213
-4%
|
202
-6%
|
192
-5%
|
190
-1%
|
187
-2%
|
175
-6%
|
|
| Operating Income | |||||||||||||||||||||||
| Operating Expenses |
(58)
|
(89)
|
(155)
|
(154)
|
(162)
|
(172)
|
(194)
|
(211)
|
(226)
|
(235)
|
(207)
|
(198)
|
(186)
|
(191)
|
(228)
|
(214)
|
(217)
|
(207)
|
(189)
|
(182)
|
(168)
|
(152)
|
|
| Selling, General & Administrative |
(44)
|
(68)
|
(114)
|
(112)
|
(120)
|
(121)
|
(128)
|
(142)
|
(138)
|
(141)
|
(100)
|
(104)
|
(98)
|
(102)
|
(129)
|
(132)
|
(134)
|
(134)
|
(109)
|
(129)
|
(125)
|
(113)
|
|
| Research & Development |
(19)
|
(29)
|
(48)
|
(54)
|
(56)
|
(65)
|
(71)
|
(83)
|
(97)
|
(101)
|
(100)
|
(99)
|
(96)
|
(98)
|
(95)
|
(93)
|
(91)
|
(80)
|
(74)
|
(62)
|
(54)
|
(50)
|
|
| Depreciation & Amortization |
0
|
0
|
(4)
|
0
|
0
|
0
|
(9)
|
0
|
0
|
0
|
(15)
|
0
|
0
|
0
|
(13)
|
0
|
0
|
0
|
(17)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
5
|
7
|
10
|
11
|
13
|
14
|
14
|
15
|
9
|
7
|
7
|
5
|
8
|
9
|
9
|
11
|
7
|
8
|
11
|
9
|
11
|
10
|
|
| Operating Income |
16
N/A
|
21
+34%
|
64
+204%
|
68
+6%
|
60
-11%
|
52
-14%
|
61
+16%
|
34
-43%
|
(8)
N/A
|
15
N/A
|
51
+239%
|
54
+6%
|
71
+31%
|
32
-54%
|
4
-89%
|
9
+156%
|
(4)
N/A
|
(5)
-28%
|
2
N/A
|
8
+255%
|
19
+149%
|
23
+19%
|
|
| Pre-Tax Income | |||||||||||||||||||||||
| Interest Income Expense |
3
|
7
|
9
|
11
|
12
|
12
|
12
|
12
|
12
|
11
|
10
|
8
|
6
|
5
|
3
|
1
|
(0)
|
(2)
|
(3)
|
(4)
|
(4)
|
(4)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(2)
|
(2)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
|
| Total Other Income |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(2)
|
(2)
|
(2)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
2
|
2
|
2
|
2
|
0
|
|
| Pre-Tax Income |
18
N/A
|
27
+48%
|
73
+168%
|
78
+8%
|
73
-7%
|
63
-14%
|
71
+12%
|
45
-36%
|
2
-95%
|
26
+1 011%
|
60
+133%
|
61
+2%
|
76
+24%
|
36
-53%
|
6
-82%
|
10
+56%
|
(5)
N/A
|
(5)
-10%
|
1
N/A
|
6
+456%
|
18
+178%
|
19
+9%
|
|
| Net Income | |||||||||||||||||||||||
| Tax Provision |
(2)
|
(4)
|
(5)
|
(6)
|
(5)
|
(1)
|
(4)
|
(3)
|
2
|
2
|
(4)
|
(4)
|
(8)
|
(7)
|
6
|
7
|
26
|
27
|
11
|
12
|
(3)
|
(5)
|
|
| Income from Continuing Operations |
16
|
24
|
68
|
72
|
68
|
62
|
66
|
42
|
4
|
27
|
56
|
57
|
68
|
29
|
13
|
17
|
22
|
22
|
12
|
18
|
15
|
14
|
|
| Income to Minority Interest |
0
|
0
|
0
|
1
|
1
|
1
|
(0)
|
(1)
|
(1)
|
(1)
|
1
|
1
|
1
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Net Income (Common) |
16
N/A
|
24
+46%
|
68
+187%
|
73
+7%
|
68
-6%
|
62
-8%
|
66
+5%
|
41
-38%
|
4
-91%
|
27
+645%
|
57
+115%
|
58
+1%
|
68
+18%
|
29
-57%
|
13
-57%
|
17
+36%
|
22
+26%
|
22
+2%
|
12
-48%
|
18
+56%
|
15
-19%
|
14
-5%
|
|
| EPS (Diluted) |
0.05
N/A
|
0.07
+40%
|
0.17
+143%
|
0.16
-6%
|
0.17
+6%
|
0.15
-12%
|
0.15
N/A
|
0.09
-40%
|
0.01
-89%
|
0.06
+500%
|
0.13
+117%
|
0.13
N/A
|
0.16
+23%
|
0.07
-56%
|
0.03
-57%
|
0.04
+33%
|
0.05
+25%
|
0.05
N/A
|
0.03
-40%
|
0.04
+33%
|
0.03
-25%
|
0.03
N/A
|
|